REPRIEVE Trademark

Trademark Overview


On Friday, January 13, 2023, a trademark application was filed for REPRIEVE with the United States Patent and Trademark Office. The USPTO has given the REPRIEVE trademark a serial number of 97753485. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, October 11, 2023. This trademark is owned by Regenesis Biomedical, Inc.. The REPRIEVE trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for inducing cell proliferation, stimulating angiogenesis, soft tissue regeneration, tissue repair and regeneration, wound healing, and pain abatement
reprieve

General Information


Serial Number97753485
Word MarkREPRIEVE
Filing DateFriday, January 13, 2023
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, October 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMedical devices for inducing cell proliferation, stimulating angiogenesis, soft tissue regeneration, tissue repair and regeneration, wound healing, and pain abatement

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, February 3, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegenesis Biomedical, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressScottsdale, AZ 85250

Trademark Events


Event DateEvent Description
Thursday, December 14, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Thursday, December 14, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, October 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 11, 2023NON-FINAL ACTION E-MAILED
Wednesday, October 11, 2023NON-FINAL ACTION WRITTEN
Wednesday, October 11, 2023ASSIGNED TO EXAMINER
Friday, February 3, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 17, 2023NEW APPLICATION ENTERED